CourageAS Biotherapeutics Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
CourageAS Biotherapeutics General Information
Description
Developer of therapeutics intended to transform the lives of individuals with Angelman syndrome.
Contact Information
Website
www.courageas.comCorporate Office
- New Jersey Bioscience Center
- 675 US Highway 1
- North Brunswick, NJ 08902
- United States
Corporate Office
- New Jersey Bioscience Center
- 675 US Highway 1
- North Brunswick, NJ 08902
- United States
CourageAS Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CourageAS Biotherapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CourageAS Biotherapeutics FAQs
-
When was CourageAS Biotherapeutics founded?
CourageAS Biotherapeutics was founded in 2025.
-
Where is CourageAS Biotherapeutics headquartered?
CourageAS Biotherapeutics is headquartered in North Brunswick, NJ.
-
What industry is CourageAS Biotherapeutics in?
CourageAS Biotherapeutics’s primary industry is Drug Discovery.
-
Is CourageAS Biotherapeutics a private or public company?
CourageAS Biotherapeutics is a Private company.
-
What is CourageAS Biotherapeutics’s current revenue?
The current revenue for CourageAS Biotherapeutics is .
-
Who are CourageAS Biotherapeutics’s investors?
Couragene and Foundation for Angelman Syndrome Therapeutics have invested in CourageAS Biotherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process